Joel Goldstein, PhD
Advertisement
Joel Goldstein, PhD is associate director, transfectoma development, at Medarex Inc.
Articles by Joel Goldstein, PhD
Advertisement
Latest Updated Articles
The Impact of Cell Culture Medium on Cell Line and Process Development Timelines and StrategiesPublished: June 2nd 2009 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Industry Outlook 2026: Biopharma Industry Confronts Skills Shortage with Strategic Automation (Part 2)
2
Next-Generation Modalities Drive New Antibody Discovery
3
New $82 Million Biopharma Launch Targets Rare Disease Development With AI-Driven Strategy
4
WHO Finalizes United States’ Withdrawal from Organization: Report
5